Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-22 Sale |
2020-12-28 8:18 pm |
Recro Pharma Inc. | REPH | SCP Vitalife Partners (Israel) II L.P. 10% Owner |
18,830 | $3.17 | $59,691 | 701,017 (Direct) |
View |
| 2020-12-22 Sale |
2020-12-28 8:18 pm |
Recro Pharma Inc. | REPH | SCP Vitalife Partners II LP 10% Owner |
56,375 | $3.17 | $178,709 | 2,097,938 (Direct) |
View |
| 2020-12-18 Sale |
2020-12-22 7:53 pm |
Recro Pharma Inc. | REPH | SCP Vitalife Partners (Israel) II L.P. 10% Owner |
6,208 | $3.0304 | $18,813 | 719,847 (Direct) |
View |
| 2020-12-18 Sale |
2020-12-22 7:52 pm |
Recro Pharma Inc. | REPH | SCP Vitalife Partners II LP 10% Owner |
18,587 | $3.0304 | $56,326 | 2,154,313 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-04-20 Option Award |
2021-04-22 5:57 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE Director |
64,935 | $0 | 314,586 (Direct) |
View |
| 2021-04-20 Option Award |
2021-04-22 5:56 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | CHURCHILL WINSTON J Director |
64,935 | $0 | 115,994 (Direct) |
View |
| 2021-04-20 Option Award |
2021-04-22 5:55 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | Berelowitz Michael Director |
64,935 | $0 | 114,558 (Direct) |
View |
| 2021-04-20 Option Award |
2021-04-22 5:55 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | Ashton William Director |
64,935 | $0 | 118,292 (Direct) |
View |
| 2021-04-13 Option Award |
2021-04-15 9:07 pm |
N/A 2031-04-13 |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-04-08 Tax Withholding |
2021-04-12 6:58 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
5,172 | $3.24 | 376,564 (Direct) |
View |
| 2021-02-09 Exercise |
2021-02-12 5:49 pm |
N/A 2031-02-09 |
Recro Pharma Inc. | REPH | Miller James Charles Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-02-03 Tax Withholding |
2021-02-12 4:10 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
1,075 | $3.74 | 381,736 (Direct) |
View |
| 2021-01-18 Tax Withholding |
2021-01-20 7:56 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
1,352 | $3.03 | 382,811 (Direct) |
View |
| 2021-01-18 Tax Withholding |
2021-01-20 7:54 pm |
N/A N/A |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE Director |
6,816 | $3.03 | 249,651 (Direct) |
View |
| 2021-01-18 Exercise |
2021-01-20 7:54 pm |
N/A N/A |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE Director |
5,000 | $0 | 249,651 (Direct) |
View |
| 2021-01-08 Option Award |
2021-01-12 5:18 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
266,000 | $0 | 384,163 (Direct) |
View |
| 2021-01-08 Tax Withholding |
2021-01-12 5:18 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
12,610 | $2.99 | 384,163 (Direct) |
View |
| 2021-01-02 Tax Withholding |
2021-01-05 5:04 pm |
N/A N/A |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE Director |
5,599 | $3.09 | 251,467 (Direct) |
View |
| 2021-01-02 Tax Withholding |
2021-01-05 4:57 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
1,210 | $3.09 | 130,773 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-18 8:57 pm |
N/A 2030-12-15 |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
195,713 | $0 | 248,488 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-18 8:55 pm |
N/A 2030-12-15 |
Recro Pharma Inc. | REPH | ENLOE J DAVID JR Chief Executive Officer |
345,990 | $0 | 345,990 (Direct) |
View |
| 2020-12-05 Tax Withholding |
2020-12-09 5:44 pm |
N/A N/A |
Recro Pharma Inc. | REPH | Lake Ryan David Chief Financial Officer |
7,611 | $2.3 | 52,775 (Direct) |
View |
| 2020-12-05 Tax Withholding |
2020-12-09 5:43 pm |
N/A N/A |
Recro Pharma Inc. | REPH | HENWOOD GERALDINE President and CEO |
34,128 | $2.3 | 257,066 (Direct) |
View |